Study of Dopamine Receptor and Dopamine Transporter Networks in Mice

Archive ouverte

Gorgievski, Victor | Tzavara, Eleni T. | Giros, Bruno

Edité par CCSD ; HUMANA PRESS INC -

International audience. Dopamine (DA) dysregulation is a core feature in Parkinson's disease and in addictive disorders. DA has been also implicated in central nervous system affective and cognitive pathologies such as bipolar disorder, schizophrenia, and attention deficit and hyperactivity disorder (ADHD). The first studies of genetically engineered mice targeting components of the DA system focused on motor behavior and on the action of addictive drugs. However, in the course of the last 20 years (the first KO relevant to the DA system to be generated were those of the D1 receptors in 1994), we have seen an increasing shift in the use of these mutants: from tools to unravel the pharmacology of addiction integrated to in vivo models to study DA-related affective and cognitive disorders.

Consulter en ligne

Suggestions

Du même auteur

Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies

Archive ouverte | El Khoury, Marie-Anne | CCSD

International audience. There is a prominent role of the cannabinoid system to control basal ganglia function, in respect to reward, psychomotor function and motor control. Cannabinoid dysregulations might have a pa...

Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum

Archive ouverte | Meffre, Delphine | CCSD

International audience. The identification of new pathways governing myelination provides innovative avenues for remyelination. Liver X receptors (LXRs) a and beta are nuclear receptors activated by oxysterols that ...

GPR56/ADGRG1 is associated with response to antidepressant treatment

Archive ouverte | Belzeaux, Raoul | CCSD

International audience. It remains unclear why many patients with depression do not respond to antidepressant treatment. In three cohorts of individuals with depression and treated with serotonin-norepinephrine reup...

Chargement des enrichissements...